Author

Galabina Bozhanova

Institute of Cancer Research

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

Alan A. MelcheriD· 2 shared Emmanuel Christian PatiniD· 2 shared Joan KyulaiD· 2 shared Kevin Joseph HarringtoniD· 2 shared Malin PederseniD· 2 shared Martin McLaughlin· 2 shared Shane FooiD· 2 shared Victoria A. JenningsiD· 2 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Alan A. MelcherORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyNature CommunicationsPeer-reviewedJul 8, 2025

PARP inhibitors enhance reovirus-mediated cell killing through the death-inducing signaling complex (DISC) with an associated NF-kappa B-regulated immune response.

Joan Kyula, Victoria Roulstone, James Wright…·Kevin Joseph Harrington

This paper identifies PARP inhibitors as sensitizers for oncolytic reovirus by enhancing DISC-mediated apoptosis and NF-kappa B-driven immune responses.

10 citations

humanmouse

𝕏 PostBluesky

Cancer BiologyJournal for ImmunoTherapy of CancerPeer-reviewedJul 1, 2024

Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T cell receptor signalling.

Edward John Lloyd Armstrong, Matthew Kin-Liang Chiu, Shane Foo…·Victoria A. Jennings

This study shows that combining oncolytic Maraba virus with PD-1 blockade overcomes resistance in advanced melanoma with a cold tumor microenvironment.

16 citations

mousebulk RNA-seq

𝕏 PostBluesky